The Immunotherapy and Immunosuppressive Signaling in Therapy-Resistant Prostate Cancer

Prostate cancer is one of the most common malignant tumors in men. Initially, it is androgen-dependent, but it eventually develops into castration-resistant prostate cancer (CRPC), which is incurable with current androgen receptor signaling target therapy and chemotherapy. Immunotherapy, specificall...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Pengfei, Wasielewski, Logan J., Yang, Joy C., Cai, Demin, Evans, Christopher P., Murphy, William J., Liu, Chengfei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9394279/
https://www.ncbi.nlm.nih.gov/pubmed/35892678
http://dx.doi.org/10.3390/biomedicines10081778

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9394279/
https://www.ncbi.nlm.nih.gov/pubmed/35892678
http://dx.doi.org/10.3390/biomedicines10081778

Ejemplares similares